IVC Filter
On this page
Direct answer
An inferior vena cava filter exists for one situation: a patient with proven proximal deep vein thrombosis or pulmonary embolism who cannot receive therapeutic anticoagulation, or whose embolism recurs despite adequate anticoagulation — it interrupts the vena cava below the renal veins, catching detached thrombus before it reaches the lungs while venous return continues. Placement is percutaneous, usually through a jugular or femoral vein under fluoroscopy, with the filter deployed infrarenally; suprarenal placement is reserved for renal vein thrombosis, pregnancy or thrombus extending into the IVC. Modern retrievable filters were designed to be removed once the contraindication to anticoagulation resolves — ideally within their indicated retrieval window, commonly weeks to a few months — because filters left in situ accumulate long-term complications: recurrence of venous thromboembolism despite the device, filter thrombosis with caval occlusion and leg oedema, migration, fracture and strut embolisation, and IVC perforation. A filter is a bridge, not a destination: it neither treats the thrombus nor replaces anticoagulation, which is resumed as soon as feasible.
What you must remember
- Accepted indications: proximal DVT or PE with an absolute contraindication to anticoagulation (active bleeding, imminent surgery, severe thrombocytopenia); recurrent PE despite therapeutic anticoagulation; inability to achieve therapeutic anticoagulation.
- Relative/selected uses: massive PE with residual thrombus and poor cardiopulmonary reserve, free-floating iliofemoral thrombus in selected patients, and neurosurgical or polytrauma patients who develop DVT and cannot be anticoagulated.
- Deployment anatomy: infrarenal IVC is standard (below the renal veins to avoid renal vein thrombosis), femoral or internal jugular access, diameter matched to caval size.
- Retrievable versus permanent: retrievable filters should be removed within their window (commonly up to about 3-6 months, device-dependent) once anticoagulation restarts — every insertion should carry a removal plan.
- Long-term filter risks: filter fracture with strut embolisation, migration (rarely to the heart), caval thrombosis and occlusion with bilateral leg swelling, insertion-site thrombosis, and post-thrombotic syndrome.
- What a filter does not do: it does not prevent DVT propagation or post-thrombotic syndrome, does not dissolve clot, and anticoagulation remains the definitive treatment of venous thromboembolism whenever possible.
- Trauma flavour: in polytrauma with proven VTE and contraindication to anticoagulation, early retrievable filter insertion followed by scheduled removal and anticoagulation when bleeding risk permits is the modern rhythm.
How to work through the decision
A 45-year-old man on therapeutic enoxaparin for iliofemoral DVT suffers a new pulmonary embolism with documented therapeutic anti-Xa levels. Anticoagulation is failing, so a filter is placed infrarenally, the anticoagulant is switched (or intensified under haematology guidance), and the plan is documented: retrieve the filter once he is stable. Contrast a 60-year-old with a fresh femoral DVT and a bleeding duodenal ulcer: anticoagulation is contraindicated right now, so a retrievable filter bridges the weeks until endoscopic haemostasis allows full anticoagulation — and the retrieval date is set at insertion, because the natural history of forgotten filters is occlusion and fracture. A third thread: a pregnant woman with iliac DVT near term may receive a suprarenal filter prior to delivery when anticoagulation must pause — an anatomical variation worth knowing. In each case the filter is scaffolding around the real treatment; the exam wants the scaffolding's indications and its removal, not admiration of the device.
How the exam frames it
The single-best-answer patterns are: "PE on adequate anticoagulation — next step" (filter); "acute DVT with active major bleeding — next step" (filter, not more anticoagulation, not thrombolysis); and "complication of a long-term indwelling filter" (caval thrombosis, fracture, migration). Equally common is the negative question — prophylactic filter placement in every high-risk trauma patient is not supported, and a filter never replaces resuming anticoagulation when it becomes safe.
Frequently asked questions
What are the standard indications for IVC filter insertion?
Proximal DVT or pulmonary embolism with an absolute contraindication to anticoagulation, or recurrent embolism despite therapeutic anticoagulation.
Where is an IVC filter typically positioned?
In the infrarenal inferior vena cava below the renal veins, deployed percutaneously via femoral or internal jugular access under fluoroscopic guidance.
Why should retrievable filters be removed promptly?
Dwelling time raises the risks of filter thrombosis, caval occlusion, fracture, strut embolisation and migration — so removal within the device's indicated window, once anticoagulation resumes, is standard practice.
Does an IVC filter treat deep vein thrombosis?
No — it only prevents emboli from reaching the lungs; anticoagulation remains the definitive treatment and is restarted as soon as safely possible.
When is suprarenal filter placement chosen?
For thrombus extending into the IVC, renal vein thrombosis, or pregnancy — situations where an infrarenal position would leave a bypass channel for emboli.